Document is current
Any future updates will be listed below
-
Authors
Ryom, Knud https://orcid.org/0000-0001-5947-3038
Bloch, Paul
Toft, Ulla
Høeg, Didde
Thomsen, Louise T.
Allender, Steven
Rutter, Harry
Bauman, Adrian
Krølner, Rikke Fredenslund
Hansen, Anders Blædel Gottlieb
-
Funding
Funding for this research was provided by:
Novo Nordisk (NNF22SA0077224)
- License Information
-
More Information
Article History
Received: 22 January 2024
Accepted: 14 December 2024
First Online: 22 January 2025
Declarations
:
: The larger GHK study is approved by the Regional Committee on Health Research Ethics for Southern Denmark (reference number S-20220094). Approval was obtained on 14 April 2023 (protocol version 1.1) with subsequent amendments approved 6 July 2023 (version 2.1), 14 July 2023 (version 2.2) and 8 August 2023 (version 3.0, current version). Any subsequent protocol amendments will be submitted to the Health Research Ethics Committee for evaluation and will also be added to the registration at (NCT05940675). Ethical approval for this study was sought and granted from the Danish Scientific Ethics Committee (S-20220059).
: Not applicable.
: The authors declare that they have no competing interests.
